435 related articles for article (PubMed ID: 27449352)
21. Malignant potential of pleomorphic xanthoastrocytoma.
Vu TM; Liubinas SV; Gonzales M; Drummond KJ
J Clin Neurosci; 2012 Jan; 19(1):12-20. PubMed ID: 22137880
[TBL] [Abstract][Full Text] [Related]
22. Angiomatous pleomorphic xanthoastrocytoma: a case report and literature review.
Jiang YF; Liu Y; Wang YL; Cao HY; Wang L; Xu HT; Li QC; Qiu XS; Wang EH
Diagn Pathol; 2016 Aug; 11(1):73. PubMed ID: 27506610
[TBL] [Abstract][Full Text] [Related]
23. Pleomorphic xanthoastrocytoma arising from the suprasellar region: A report of two cases.
Jiang GY; Yu JH; Zhang XY; Qi XL; Sun YS
J Clin Neurosci; 2016 Nov; 33():228-231. PubMed ID: 27452134
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
[TBL] [Abstract][Full Text] [Related]
25. Pleomorphic xanthoastrocytoma and moyamoya disease in a patient with neurofibromatosis type 1 - case report - .
Horiguchi S; Mitsuya K; Watanabe R; Yagishita S; Nakasu Y
Neurol Med Chir (Tokyo); 2011; 51(4):310-4. PubMed ID: 21515957
[TBL] [Abstract][Full Text] [Related]
26. Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
Tanaka S; Nakada M; Nobusawa S; Suzuki SO; Sabit H; Miyashita K; Hayashi Y
Brain Tumor Pathol; 2014 Jul; 31(3):172-6. PubMed ID: 24894018
[TBL] [Abstract][Full Text] [Related]
27. Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation.
Koga T; Morita A; Maruyama K; Tanaka M; Ino Y; Shibahara J; Louis DN; Reifenberger G; Itami J; Hara R; Saito N; Todo T
Neuro Oncol; 2009 Aug; 11(4):446-51. PubMed ID: 19164434
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of pleomorphic xanthoastrocytoma.
Nakajima T; Kumabe T; Shamoto H; Watanabe M; Suzuki H; Tominaga T
Acta Neurochir (Wien); 2006 Jan; 148(1):67-71; discussion 71. PubMed ID: 15912255
[TBL] [Abstract][Full Text] [Related]
29. Malignant progression of a pleomorphic xanthoastrocytoma in a child.
Alexiou GA; Moschovi M; Stefanaki K; Prodromou C; Sfakianos G; Prodromou N
Neuropediatrics; 2010 Aug; 41(2):69-71. PubMed ID: 20799153
[TBL] [Abstract][Full Text] [Related]
30. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature.
Perry A; Giannini C; Scheithauer BW; Rojiani AM; Yachnis AT; Seo IS; Johnson PC; Kho J; Shapiro S
Am J Surg Pathol; 1997 Jul; 21(7):763-71. PubMed ID: 9236832
[TBL] [Abstract][Full Text] [Related]
31. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Matsumura N; Nakajima N; Yamazaki T; Nagano T; Kagoshima K; Nobusawa S; Ikota H; Yokoo H
Neuropathology; 2017 Feb; 37(1):58-63. PubMed ID: 27302309
[TBL] [Abstract][Full Text] [Related]
32. Cytologic features of pleomorphic xanthoastrocytoma, WHO grade II. A comparative study with glioblastoma.
Jiménez-Heffernan JA; Freih Fraih A; Álvarez F; Bárcena C; Corbacho C
Diagn Cytopathol; 2017 Apr; 45(4):339-344. PubMed ID: 28084690
[TBL] [Abstract][Full Text] [Related]
33. Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1: a case report and literature review.
Takei H; Rouah E; Bhattacharjee MB
Int J Clin Exp Pathol; 2015; 8(6):7570-4. PubMed ID: 26261671
[TBL] [Abstract][Full Text] [Related]
34. Response to BRAF/MEK Inhibition After Progression With BRAF Inhibition in a Patient With Anaplastic Pleomorphic Xanthoastrocytoma.
Hussain F; Horbinski CM; Chmura SJ; Yamini B; Lukas RV
Neurologist; 2018 Sep; 23(5):163-166. PubMed ID: 30169370
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components.
Hattab EM; Martin SE; Shapiro SA; Cheng L
J Neurosurg; 2011 Jun; 114(6):1648-53. PubMed ID: 21214337
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature.
Sasaki S; Tomomasa R; Nobusawa S; Hirato J; Uchiyama T; Boku E; Miyasaka T; Hirose T; Ohbayashi C
Brain Tumor Pathol; 2019 Oct; 36(4):169-173. PubMed ID: 31350684
[TBL] [Abstract][Full Text] [Related]
37. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin.
Martinez-Diaz H; Kleinschmidt-DeMasters BK; Powell SZ; Yachnis AT
Arch Pathol Lab Med; 2003 Sep; 127(9):1187-91. PubMed ID: 12946225
[TBL] [Abstract][Full Text] [Related]
38. Spinal imaging in intracranial primary pleomorphic xanthoastrocytoma with anaplastic features.
Nern C; Hench J; Fischmann A
J Clin Neurosci; 2012 Sep; 19(9):1299-301. PubMed ID: 22789631
[TBL] [Abstract][Full Text] [Related]
39. Non-anaplastic pleomorphic xanthoastrocytoma with neuroradiological evidences of leptomeningeal dissemination.
Passone E; Pizzolitto S; D'Agostini S; Skrap M; Gardiman MP; Nocerino A; Scarzello G; Perilongo G
Childs Nerv Syst; 2006 Jun; 22(6):614-8. PubMed ID: 16369851
[TBL] [Abstract][Full Text] [Related]
40. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.
Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T
World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
